CERo Therapeutics Holdings, Inc.

CERO · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$8-$7-$12-$11
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$2$1$2-$0
Other Non-Cash-$1-$0$7$9
Operating Cash Flow-$6-$6-$1-$1
Investing Activities
PP&E Inv.$0$0-$1-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$14-$0$0
Inv. Sales/Matur.$0$6$0$0
Other Inv. Act.$0$9$182-$178
Investing Cash Flow$0-$0$181-$179
Financing Activities
Debt Repay.-$0$1$1$0
Stock Issued$14$0$0$180
Stock Repurch.$0-$0-$139$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$13$0-$139$0
Financing Cash Flow$1$1-$139$180
Forex Effect$0$0$0$0
Net Chg. in Cash-$5-$5$41$1
Supplemental Information
Beg. Cash$7$7$1$30
End Cash$2$2$42$1
Free Cash Flow-$6-$6-$2-$1